Orexo AB announced new topline results of 2 clinical trials with a combination of buprenorphine and naloxone for buprenorphine induction and plans to pursue approval of an expanded label in the US. Medscape Medical News (Source: Medscape Medical News Headlines)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.